ArticleInternal and emergency medicine2026
Closed-loop protocol for inferior vena cava filter management significantly improves retrieval: a competing-risk analysis of a 10-year cohort.
Article in Internal and emergency medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inferior vena cava (IVC) filters are indicated only in acute venous thromboembolism (VTE) with an absolute contraindication to anticoagulation and should be retrieved once anticoagulation can be resumed. However, real-world retrieval rates remain low and highly variable. The objective is to assess whether implementing an institutional protocol improved appropriateness of IVC-filter placement and retrieval rates at 90 and 180 days, and to evaluate safety outcomes. Retrospective pre-post single-center study including adults who received an IVC filter between January 2015 and July 2025. Co-primary outcomes were appropriateness at placement (acute VTE ≤ 30 days plus absolute contraindication to anticoagulation) and retrieval, evaluated at 90 and 180 days using Fine-Gray competing-risk models. Among 234 patients (pre n = 182; post n = 52), cancer prevalence was similar (40.1% vs 38.5%). Appropriateness increased from 74.7% to 88.5% (risk ratio 1.18, 95% CI 1.04-1.35; p = 0.036). Retrieval improved at day 90 (41.2% → 65.4%, p = 0.020) and at day 180 (41.8% → 73.1%, p < 0.001). In Fine-Gray models, the post-protocol period was associated with a higher cumulative incidence of retrieval (adjusted sub-HR 1.68 [1.16-2.43] at 90 days; 1.92 [1.39-2.66] at 180 days), consistent with cause-specific Cox estimates. Procedure-related complications did not increase. Although overall mortality was unchanged, retrieval was independently associated with lower 180 days (adjusted HR 0.20 [0.08-0.48]). Implementing a closed-loop, guideline-aligned protocol improved appropriateness and substantially increased IVC-filter retrieval without compromising safety. Older age and active cancer remained barriers to retrieval, highlighting priority groups for targeted follow-up strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.